Chronic Heart Failure Flashcards

(82 cards)

1
Q

Etiology of HF

A

Heart is not able to apply sufficient oxygen rich blood to the body because of impaired ability of the left ventricle to fill or eject blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diagnosis ejection fraction

A

echocardiogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

LVEF ≥50

A

HFpEF: impaired ventricular relaxation and filling during diastole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

41-49% EF

A

HFmrEF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is HFimpEF

A

≤40% at baseline but improves to >40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LVEF ≤40%

A

HFpEF: impaired ability to eject blood during systole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the ACC/AHA staging

A

Structural classification
A: Patient is at risk with no sx
B: Pre-HF with structural heart disease with no signs of sx
C: Structural abnormalities with sx
D: Advanced (refractory) HF requiring hospitalization (ADHF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the NYHA functional classes?

A

I: No limitations to physical activity
II: Slight limitation but ordinary activity → sx of HF
III: Marked limitations with minimal exertion
IV: Unable to carry out physical activity without sx of HF or sx at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are labs of HF

A

BNP >100
NT-proBNP >300

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sx of left sided HF

A

Orthopnea: SOB when lying flat
Paroxysmal nocturnal dyspepsia: nocturnal cough and SOB
Rales: crackling
S3 gallop
Hypoperfusion: renal impairment or cool extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

General sx of HF

A

Dyspepsia
Cough
Fatigue, weakness
Reduced exercise capacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Sx of right sided HF

A

Peripheral edema
Ascites
JVD
HJR
Hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is cardiac output

A

Volume of blood that is pumped by the heart in 1 min

CO = HR x SV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How to calculate Cardiac index

A

CI = CO/BSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the compensatory mechanism of HFrEF

A

Low cardiac output → activation of neurohormonal pathways (RAAS) → ↑ blood volume and force of contraction → chronic compensation leads to cardiac remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Activity of Ang2

A

Vasoconstriction → release aldosterone and vasopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Activity of aldosterone

A

Sodium and water retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Activity of vasopressin

A

Vasoconstriction and water retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lifestyle counseling of HF

A
  1. Monitor body weight
  2. Notify provider if weight ↑ 2-4 lbs in one day or ≥5 lbs in a week
  3. Avoid sodium ≤1.5g/day
  4. Restrict fluid 1.5-2L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Natural products used for HF

A

CoEnzyme Q10
Hawthorn
Omega 3 FA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Drugs that worsen HF

A

DDP-4 (alogliptin and saxagliptin)
Immunosuppressants (TNF inhibitors)
Non-DHP CCB
Antiarrhythmics (CI, amiodarone, and dofetalide)
TZDs
Itraconazole
Oncology drugs (Doxorubicin and daunarubicin)
NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the GDMT drugs

A

ARNI, ACEI, or ARB: reduce mortality and morbidity
BB: reduce mortality and hospitalizations
MRAs: reduce morbidity and mortality
SGLT2I: reduce hospitalization and mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Medication that is preferred in HFmrEF?

A

SGLT2i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

MOA of entresto

A

Sacubitril: neprilysin inhibitor, an enzyme responsible for degradation of vasodilatory peptides (BNP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Target dose of entresto
97/103 mg BID
25
BBW of entresto? CI?
Teratogenic CI: do not use with or within 36 hrs of an ACI, angioedema
26
ADRS of entresto?
Angioedema, hyperkalemia, renal impairment (bilateral renal artery stenosis), hypotension, cough
27
Target dose of enalapril
10-20 mg PO BID
28
Target dose of lisinopril
20-40 mg QD
29
Target dose of quinapril
20 mg BID
30
Target of ramipril?
10 mg QD
31
Target dose of losartan
50-150 mg QD
32
Target dose of valsartan?
160 mg BID
33
BB indicated for HF
Bisoprolol, metoprolol succinate, carvedilol
34
When do you DC BB for HF
ADHF if hypotension or hypo perfusion is present Intrinsic sympathomimetic activity
35
Target dose of metoprolol succinate
200 mg QD
36
Target dose of bisoprolol
10 mg QD
37
Target dose of carvedilol
CR: 80 mg QD IR: - ≤85 kg: 25 mg BID - >85 kg: 50 mg BID
38
Warning and ADR of BB
Warning: diabetes (masking hypoglycemia except sweating), asthma, COPD, Raynaud's ADR: bradycardia, hypotension, CNS effects (fatigue, DZ, depression), impotence
39
Metoprolol IV to PO
IV:PO is 1:2.5 ratio
40
Counseling of Toprol XL
Can be cut in half and should be taken with or immediately after meals
41
Counseling of carvedilol
Take with food
42
Carvedilol CR to IR
Coreg IR 3.125 mg BID = Coreg CR 10 mg QD
43
Difference between spironolactone and eplerenone
Spir: non-selective → endocrine ADRs Eple: selective → no endocrine ADRs
44
CI of MRAs
Hyperkalemia >5, severer renal impairment, Addison's
45
Spironolactone ADR
Gynecomastia, breast tenderness, impotence
46
Target dose of Spironolactone
25-50 mg QD
47
Target dose of eplerenone
50 mg QD
48
Target dose of dapagliflozin
10 mg QD
49
Target dose of empagliflozin
10 mg QD
50
Sotagliflozin target dose
200-400 mg QD
51
When should you not initiate SGLT2I
eGFR <20-25
52
When should you not initiate MRAs
K >5 mEq/L CrCl ≤30 sCr >2 (females), >2.5 (males)
53
Site of action for loops
Ascending loop of Henle
54
What is loops for HF
Doesn't not improve survival but used for sx control
55
Warning of loops
Ototoxicity Sulfa allergy (not ethacyrnic acid) AKI
56
Loop conversions
Furosemide = Torsemide = Bumetanide = Ethacrynic acid 40 mg = 20 mg = 1 mg = 50 mg Furosemide IV = PO → 1:2
57
Loops DDI
↑ lithium levesl
58
ADR of loops
↓ : K, Mg, Na, Ca, Cl ↑ : UA. BG. TG, TC, HCO3 Orthostatic hypotension, photosensitivity
59
MOA of hydralazine? Nitrates?
Hydralazine: Direct arterial vasodilator → ↓ afterload Nitrates: Venous vasodilator → ↓ preload
60
Why is BiDil recommended?
Improves survival: for patients who can't tolerate ACE, ARB, or ARNI due to poor renal function, angioedema, hyperkalemia Indicated for self-identified Blacks
61
ADR and warning of hydralazine
DILE, peripheral edema, flushing, palpitations, reflex tachycardia
62
ADR and warning of isosorbide dinitrate?
CI: PDE5I ADR: hypotension, HA, DZ, tachyphylaxis (need 10-12 hr nitrate free interval), syncope
63
MOA of ivabridine
Disrupts the "funny" current in the SA node → ↓ rate of firing → reduce HR
64
What is Ivabridine used for?
Adjunct therapy for patients already on GDMT max doses to reach a resting HR ≥70 bpm
65
MOA of digoxin
Inhibits Na-K-ATPase pump → positive inotropic effect (↑ contractility and CO) but negative chronotropic (↓ HR)
66
Purpose for digoxin
Improves sx, exercise intolerance, and quality of life
67
Serum level for digoxin in HF
0.5 - 0.9 ng/mL
68
Typical dose of digoxin
0.125 - 0.25 mg
69
Dosing of digoxin PO to IV
Reduce PO dose by 20-25% for IV dose
70
Signs of digoxin toxicity
N/V, loss of appetite, blurred/double vision, greenish-yellow halos, bradycardia, arrhythmias HYperkalemia, hypomagnesemia, hypercalemia
71
Antidote for digoxin
DigiFab
72
Dosing adjustment with concurrent amiodarone
Reduce digoxin dose by 50%
73
MOA of vericiguat
Soluble guanylate cyclase stimulator → increase cyclic GMP and leads to smooth muscle relaxation and vasodilation
74
Purpose of veriiciguat
Patient with persistent sx of HF with optimized GDMT
75
ADR of viriciguat
Hypotention
76
ER capsules of K
Klor-Con sprinkle, Micro-K
77
ER tabs of K
K-Tab, Klor-con (M)
78
PO solution strengths of K
10% (20 mEq/15 mL0 20% (40 mEq/15mL)
79
Counseling on ER capsules of K
Contents can be sprinkled on applesauce or pudding
80
Counseling on ER tabs of K
K-tab, Klor-con: swallow whole Klor-con M: if difficult to swallow, cut in half or dissolve in water (stir for 2 min and drink immediately)
81
Counseling of Po K solution
Mixing each 15 mL with 6 oz of water